Cargando…
The endocannabinoid system – current implications for drug development
In this review, the state of the art for compounds affecting the endocannabinoid (eCB) system is described with a focus on the treatment of pain. Amongst directly acting CB receptor ligands, clinical experience with ∆(9)‐tetrahydracannabinol and medical cannabis in chronic non‐cancer pain indicates...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358957/ https://www.ncbi.nlm.nih.gov/pubmed/33348434 http://dx.doi.org/10.1111/joim.13229 |